Roman-Ulrich Müller
@muellerrom.bsky.social
85 followers 19 following 53 posts
passionate for translational research...kidney disease and beyond...
Posts Media Videos Starter Packs
Reposted by Roman-Ulrich Müller
cga-age.bsky.social
📹 Interested in a PhD position in aging research starting in 2026? Then watch our new short video for some tips from our wonderful PhD students and faculty.
Don't miss the deadline: November 3, 2025.
Apply now and start your journey with us!
Reposted by Roman-Ulrich Müller
markusathome.bsky.social
KDIGO 2025 ADPKD Guideline: A commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney by Drs. @muellerrom.bsky.social , @joostphdrenth.bsky.social, et al.

academic.oup.com/ndt/article/...
muellerrom.bsky.social
CKDx: Simplicity matters, implementation is key url: academic.oup.com/ndt/article/...

At this stage, it is all about widespread adoption of a simple concept: we do not always know the diagnosis in kidney disease. And reporting diagnostic steps in a simple manner enables us to go the next step.
CKDx: Simplicity matters, implementation is key
Emilie Cornec-Le Gall, Jan Halbritter, Roman Ulrich Müller; CKDx: Simplicity matters, implementation is key, Nephrology Dialysis Transplantation, , gfaf137
academic.oup.com
Reposted by Roman-Ulrich Müller
cga-age.bsky.social
Apply now for a fully funded #PhD position at the Cologne Graduate School of Ageing Research and become part of our vibrant #AgingResearch commmuny.
🗓️ Deadline: November 3, 2025.
ℹ️ More info: www.ageing-grad-school.de
📣 Spread the news!
muellerrom.bsky.social
Absolutely. But still no funding to implement these spectacular findings…😉 I guess this will be a long learning process for policymakers…
Reposted by Roman-Ulrich Müller
Reposted by Roman-Ulrich Müller
pkdinternational.bsky.social
KDIGO ADPKD Guideline: A Milestone in Genetic Kidney Diseases Why is a global guideline for ADPKD so important?

Prof. Roman Müller explains how the new KDIGO guideline marks a crucial step forward in harmonizing care for patients with #ADPKD) worldwide 👇
muellerrom.bsky.social
Great thanks to Jörg Bernards-Stiftung and @dfg.de (Excellence Strategy @cecad.bsky.social) for supporting this work and to all patients participating.
unicologne.bsky.social
Predicting kidney disease trajectories with a simple blood test🩸
A research team around @muellerrom.bsky.social has developed a new approach to predict the progression of kidney disease via 29 proteins in the blood that are associated with the decline of kidney function.
▶️https://uni.koeln/3U6M5
Predicting kidney disease trajectories with a simple blood test
A University of Cologne research team has developed a novel approach to predict how fast kidney disease is likely to progress, using just blood samples. They discovered 29 proteins that are linked to ...
uni.koeln
muellerrom.bsky.social
Untargeted. Targeted assays for absolute quantification in a prospective study will now have to be the next step towards implementation
muellerrom.bsky.social
📎 Read the full study here: Nature Commun. 16, 6646 (2025) – DOI 10.1038/s41467-025-61887-8
muellerrom.bsky.social
10/ This work was enabled by all patients participating and central support by the Jörg Bernards-Stiftung and @DFG through the Excellence Initiative (@CECAD). Thank you!
@cecad.bsky.social @unicologne.bsky.social @uniklinikkoeln.bsky.social and Center for Molecular Medicine Cologne
muellerrom.bsky.social
9/ Next steps:
• Develop targeted assays for the 6 proteins
• Prospective multicenter validation
• Explore integration with other data layers (e.g. metabolomics) and treatment response
• Ultimate goal: precision-medicine profiling for ADPKD care rdcu.be/exbNq
muellerrom.bsky.social
8/ Why it matters:
✅ Blood-based protein markers are inexpensive and accessible
✅ They improve prediction where MRI and genetics may fall short
✅ Pave the way for targeted assays (e.g. ELISA, mass spec) and prospective clinical use rdcu.be/exbNq
muellerrom.bsky.social
7/ Notably, the proteome data adds predictive information independent of eGFR at baseline. In ROC analysis for identifying rapid progressors (>3 ml/min/yr) adding the protein to MIC enhanced the AUC rdcu.be/exbNq
muellerrom.bsky.social
6/ These models were cross-validated in two large cohorts: an internal cohort (Cologne) and an external cohort using EDTA plasma instead of serum (Groningen). rdcu.be/exbNq
muellerrom.bsky.social
5/ The model based on these 6 proteins was superior to a clinical standard model based on eGFR and Mayo Imaging Class (MIC). Adding the proteins to the clinical standard further improved the model. rdcu.be/exbNq
muellerrom.bsky.social
4/ Using weighted LASSO, we narrowed it to 6 key proteins:
• GPX3 (oxidative stress)
• SERPINF1 (angiogenesis regulator)
• AFM (vitamin E transport)
• FERMT3 (cell adhesion)
• CFHR1 (complement pathway)
• RARRES2 (inflammation/adipogenesis) rdcu.be/exbNq
muellerrom.bsky.social
3/ We analyzed serum from large cohorts via semi-automated mass spectrometry. Identified 29 proteins significantly linked to yearly eGFR decline rdcu.be/exbNq